Conmed (CNMD) Treasury Shares (2010 - 2026)

Conmed's Treasury Shares history runs 17 years deep, the most recent figure standing at $49.0 million for Q1 2026.

• Quarterly Treasury Shares rose 237.98% year-over-year to $49.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $49.0 million (up 237.98% YoY) and the FY2025 annual result came in at $12.9 million, down 17.53% from the prior year.
• Treasury Shares was $49.0 million for Q1 2026 at Conmed, up from $12.9 million in the prior quarter.
• Across five years, Treasury Shares topped out at $1.8 million in Q1 2022 and bottomed at $46000.0 in Q4 2022.
• A 5-year average of $585810.0 and a median of $508028.0 in 2024 frame the typical range for Treasury Shares.
• Annual changes were most pronounced in 2022 — Treasury Shares sank 60.86% — and 2026, when it jumped 237.98%.
• Conmed's Treasury Shares stood at $22.8 million in 2022, then slumped by 34.2% to $15.0 million in 2023, then gained by 4.27% to $15.6 million in 2024, then slipped by 17.53% to $12.9 million in 2025, then surged by 280.55% to $49.0 million in 2026.
• Business Quant data shows CNMD's Treasury Shares at $49.0 million in Q1 2026, $12.9 million in Q4 2025, and $13.5 million in Q3 2025.